Vorozole

Vorozole is a brand-name prescription medication used to treat advanced ovarian cancer. It belongs to a class of medications called aromatase inhibitors. Vorozole works by blocking the production of the female hormone estrogen, which can help slow the growth of certain types of cancer cells. It is typically used in combination with other medications and is taken orally, usually once daily. Common side effects of Vorozole include hot flashes, night sweats, fatigue, joint pain, nausea, and vomiting.

Vorozole, though researched for medical applications, is not currently a prescribed medication. Here's what we know about it:

• Development: Vorozole is a triazole-based inhibitor of the aromatase enzyme [1, 2]. Aromatase is an enzyme responsible for converting androgens (male sex hormones) into estrogens (female sex hormones) [2].
• Intended Use: Due to its ability to block estrogen production, vorozole was being investigated as a potential treatment for hormone-receptor-positive breast cancer in postmenopausal women [2, 3]. This type of breast cancer relies on estrogen for growth.
• Clinical Trials: Vorozole underwent clinical trials to assess its effectiveness against breast cancer [2, 3]. While it showed promise in reducing estrogen levels and some tumor shrinkage, further development was halted [2].
• Reason for Halt: Research focused on other third-generation aromatase inhibitors, like anastrozole, letrozole, and exemestane, which ultimately proved to be more effective or have a better side effect profile [2].